Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 70121-1452

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 70121-1452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dexamethasone Sodium Phosphate Injection Usp 4 mg 1)

FDA Label Image

1 (Dexamethasone Sodium Phosphate Injection Usp 4 mg 2)

FDA Label Image

2 (Dexamethasone Sodium Phosphate Injection Usp 4 mg 3)

FDA Label Image

3 (Dexamethasone Sodium Phosphate Injection Usp 4 mg 4)

3 (Dexamethasone Sodium Phosphate Injection Usp 4 mg  4)
This is a medication, distributed by Amneal Pharmaceuticals LLC, in a 5 ml vial containing Dexamethasone Sodium Phosphate. It is intended for intramuscular or intravenous use and should be stored at controlled room temperature. The package insert should be consulted for additional information and specific instructions for use.*
FDA Label Image

4 (Dexamethasone Sodium Phosphate Injection Usp 4 mg 5)

4 (Dexamethasone Sodium Phosphate Injection Usp 4 mg  5)
The text contains a mix of different fragments of texts. It is not clear what it refers to or what it is about. The output is not available for interpretation.*
FDA Label Image

5 (Dexamethasone Sodium Phosphate Injection Usp 4 mg 6)

5 (Dexamethasone Sodium Phosphate Injection Usp 4 mg  6)
This is a description of a medication called Dexamethasone Sodium Phosphate Injection, USP, available in a 30 mL multiple dose vial for intravenous, intramuscular, intra-articular, soft tissue or intralesional use. It contains 4.37 mg of Dexamethasone Sodium Phosphate USP equivalent to 4 mg of Dexamethasone Phosphate, as well as sodium sulfite, benzyl alcohol, and water for injection. The medication is stored at 20° to 25°C and protected from light. The manufacturer is Amneal Pharmaceuticals Put. Ltd. in Anmedabad, India, and it is distributed by Amneal Pharmaceuticals LG in Bridgewater, NJ. Directions for use are included in the package insert, and this information was last revised in May 2019. Lot No: 70121 | 14521|*
FDA Label Image

6 (Dexamethasone Sodium Phosphate Injection Usp 4 mg 7)

6 (Dexamethasone Sodium Phosphate Injection Usp 4 mg  7)
This is a description of Dexamethasone Sodium Phosphate Injection, USP. Each 30ml multiple dose vial contains 120mg and is suitable for intravenous, intramuscular, intra-articular, soft tissue, or intralesional use. The product contains Dexamethasone Sodium Phosphate, equivalent to Dexamethasone Phosphate, Sodium Sulfate 1 mg, Benzyl Alcohol 10 mg, Water for Injection g, and Sodium Citrate for isotonicity. It is PH adjusted with Citric Acid and/or Sodium Hydroxide. The product is manufactured by 'Amneal Pharmaceuticals Pvt Ltd and distributed by Amneal Pharmaceuticals LLC. It should be stored at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) and protected from light. The package insert contains instructions for use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.